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HIV-2 disease progression and transmission is attenuated
compared to HIV-1, yet prospective studies examining
HIV-2 intrapatient evolution have been limited. We exam-
ined viral sequence evolution in the C2V3C3 region of the
viral env gene in 8 HIV-2 infected individuals from Dakar,
Senegal, over the course of approximately 10 years. To
compare results to HIV-1 infection, we reanalyzed data
from our previous study that examined intrapatient evolu-
tion in HIV-1 infected individuals from the same popula-
tion. HIV-2 sequences from early and late timepoints were
phylogenetically intermixed for all subjects, and no dis-
tinct trends were observed in terms of increases or
decreases in fragment size or number of N-linked glyco-
sylation sites. In homologous env C2V3 sequence, rates of
viral divergence and diversification were slower in indi-
viduals infected with HIV-2 than individuals with HIV-1.
This data indicates that viral evolution occurs slowly in
HIV-2 infection, which is consistent with the slow disease
progression observed in HIV-2 infection, and supports the
notion that viral evolution may be a relevant correlate for
disease progression.
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